Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 103,025

Document Document Title
WO/2019/006700A1
Provided are a Bacillus subtilis strain JSC-137 producing 5-hydroxytryptophan and a method for producing 5-hydroxytryptophan by using the same with tryptophan as a substrate. The Bacillus subtilis strain JSC-137 has a collection number o...  
WO/2019/008272A1
The present invention concerns a mutant strain of Sarcocystidae in which the two genes mic1 and mic3 are deleted, containing two specific recombination sites of an enzyme enabling a specific recombination in particular Cre recombinase, s...  
WO/2019/007055A1
Provided are a recombinant microorganism for producing cytidine diphosphate and a method for producing cytidine diphosphate using the recombinant microorganism.  
WO/2019/006701A1
A Bacillus licheniformis strain JSC-69 producing 5-hydroxytryptophan and having a collection number of CGMCC NO: 13533 and a method for producing 5-hydroxytryptophan by using the Bacillus licheniformis strain. The Bacillus licheniformis ...  
WO/2019/008303A1
The present invention relates to a method for restoring sexual reproduction between two sterile, female strains of Tichoderma reesei using a helper strain ∆MAT, said helper strain being a fertile female strain of Trichoderma reesei in ...  
WO/2019/006534A1
Methods, uses, compositions and kits for treating steroid-resistant chronic rhinosinusitis (CRS), including refractory CRS, in a subject, or for improving or restoring the response to anti- inflammatory sinus treatment in a patient suffe...  
WO/2019/006723A1
Provided is a mesophilic microorganism host cell that produces lysine, and is genetically modified to express a thermophilic lysine decarboxylase and to overexpress one or more lysine biosynthesis polypeptides. And provided are methods o...  
WO/2019/008131A1
The invention refers to a recombinant Pseudomonas putida host cell capable of producing D-xylonate (D-xylonic acid) from D-xylose and a method for producing D-xylonate using the same. The recombinant P. putida host cell according to the ...  
WO/2019/008274A1
The present invention relates to a mutant strain of Sarcocystidae wherein the function of at least one virulence-essential protein is suppressed, characterised in that said strain contains at least one nucleic acid respectively encoding ...  
WO/2019/010116A1
Aquafeed, animal feed, and other food products, as well as nutritional and pharmaceutical compounds, chemicals and biomaterials are important commodities that can be produced at commercial scale by fermentation of microorganisms. The pre...  
WO/2019/009407A1
The problem addressed by the present invention is to provide a novel drug for treating haemorrhagic disorders which has a superior blood-coagulating effect, and a method for treating haemorrhagic disorders which uses said drug. Provided ...  
WO/2019/010369A1
Disclosed are recombinant mutant Candida utilis uricase enzymes with improved pancreatin stability and/or activity, compositions containing such uricase enzymes, which can be used, among other things, to treat diseases or disorders assoc...  
WO/2019/009388A1
The purpose of the present invention is to provide: an anti-human CEACAM5 antibody Fab fragment which is expected as useful in diagnosing cancer, in particular, colon cancer, breast cancer, lung cancer, thyroid cancer or cancer metastasi...  
WO/2019/008273A1
The present invention relates to a mutant strain of Sarcocystidae in which the function of the MIC1 protein and the function of the MIC3 protein are suppressed, for use in the prevention of infectious diseases in poultry.  
WO/2019/010282A1
This invention provides for a dry preserved formulation of Lactobacillus suitable for administration to people as a pro-biotic or live biotherapeutic treatment where the formulation is stable, has high potency, and contains no animal-der...  
WO/2019/004615A1
The present invention relates to: Metarhizium anisopliae JEF-197(KFCC11720P) and Metarhizium anisopliae JEF-279( KFCC11721P), which are novel strains having a control effect on Monochamus alternatus; a pest control composition containing...  
WO/2019/002914A1
The present invention relates to the strain of Lactobacillus reuteri LMG P-27481 provided with anti-inflammatory activity, immunomodulatory activity and capability of inhibiting pathogenic microorganisms. The microorganism can result to ...  
WO/2019/001548A1
Provided is a method for preparing fucoxanthin by fermental cultivation of Nitzschia laevis, comprising the following process steps: step A: preparation of a seed solution; step B: fermental cultivation: transferring the seed solution to...  
WO/2019/004347A1
Provided is a method with which it is simple to determine the contraction or risk of contracting gingivitis, and which can be used in mass screening. The method entails measuring the abundance ratio or amount of marker bacteria with resp...  
WO/2019/000028A1
A mosquito-adapted Wolbachia pipientis var wMelCS bacterium is provided which is particularly efficacious for infecting mosquitoes that can harbour highly infectious viruses. Mosquitoes infected with the wMelCS bacterium may be released ...  
WO/2019/006262A1
Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide ribos...  
WO/2019/006341A1
Disclosed herein are genetically modified microorganisms and related methods for enhanced utilization of oligosaccharides and improved productivity of compounds derived from the metabolism of the oligosaccharides. The microorganisms desc...  
WO/2019/004381A1
Provided are: a transplant chamber which is highly durable and which efficiently ensures an internal space thereof, and which can maintain biological substances encapsulated therein for long periods; and a method for producing same. This...  
WO/2019/002512A2
Described herein are compositions and methods of producing glycosylated proteins in vitro and in vivo. The methods include using host cells to produce glycosylated proteins. Also described herein are glycosylated proteins produced using ...  
WO/2019/006255A1
The present invention relates to recombinant host cells polynucleotides and polypeptides, methods for their production, and methods for their use in production of hydrocarbons. Disclosed herein are methods, compositions and hosts for syn...  
WO/2019/003180A1
Disclosed herein are underlying aspects, including optimized media and growth conditions, for the enhanced secretion of a self-assembling extracellular self assembling native protein from a Yarrowia lipolytica strain through liquid cultu...  
WO/2019/000850A1
The present invention provides a dendrobium officinale endophytic fungi strain and an extracellular polysaccharide produced thereby as well as an extraction method and application of the extracellular polysaccharide. The extraction proce...  
WO/2019/004234A1
The present invention addresses the problem of providing a simple method for producing ergothioneine. Provided is an ergothioneine production method characterized by comprising a step for culturing a microorganism belonging to the genus ...  
WO/2019/006257A1
Disclosed herein are methods, compositions, and hosts for synthesizing hydrocarbons, and derivatives thereof, comprising one or more isoprene units as well as salts or derivatives thereof. An aspect of the present invention thus relates ...  
WO/2019/003283A1
Provided is a culture which has a mild rose fragrance and is suitable for imparting a rose fragrance to cosmetics, foods, beverages, medicines, and so forth. The culture is obtained by using kluyveromyces marxianus to ferment a lactobaci...  
WO/2019/003239A1
The present invention discloses a rapid high yielding purification process for Neisseria meningitidis serogroup X capsular polysaccharide. The capsular polysaccharide of present invention is capable of being used in the production of eco...  
WO/2019/004213A1
Provided is technology for using a particular antigen-binding peptide as an intrabody that is intracellularly functioning stably. An intracellularly-stabilised peptide comprising 10–39 amino acids, at least 45% of which are acidic, is ...  
WO/2019/001269A1
A pseudomonas sp., a method thereof for preparing a dual-function enzyme preparation, and applications thereof. A pseudomonas sp. ECO-1 strain is separated from soil polluted by a persistent organic pollutant, and a dual-function enzyme ...  
WO/2019/004346A1
Provided is a method with which it is easy to determine the contraction or risk of contracting gingivitis, and which can be used in mass screening. This method entails measuring the abundance ratio or quantity of marker bacteria with res...  
WO/2019/004217A1
Provided are: a method for separating mammalian sperms, whereby it becomes possible to separate a large quantity of sperms within a short time and it also becomes possible to prevent the deterioration in movement of the separated sperms;...  
WO/2019/002634A1
The present invention relates to a method for producing a yeast-based product with a high nucleotide concentration, specifically with a nucleotide content of more than 80% by weight. The method is essentially based on carrying out a firs...  
WO/2018/235743A1
The present invention addresses the problem of providing an efficient treatment method for organic compounds by using constitutive 1,4-dioxane degrading bacteria of strain N23. To solve this problem, there is provided a biodegradation tr...  
WO/2018/235958A1
The purpose of the present invention is to provide a method for purifying protein which does not use polar solvents such as dimethyl sulfoxide (DMSO), a method for producing a protein solution, and a method for producing a protein moulde...  
WO/2018/234599A1
Bacterial strain Bacillus amyloliquefaciens QV15 (CECT 9371), a microorganism from the group of Gram + bacteria, genus Bacillus, a stimulant for the secondary metabolism of phenolic compounds, enhancer of the extracts from raspberry and ...  
WO/2018/234914A1
A method designed to clarify the coffee oil contained in coffee grounds or in whole and/or damaged coffee beans. Said objective is achieved by way of a method that starts with inoculation of the coffee grounds or coffee beans with macrom...  
WO/2018/237316A1
In certain aspects, described herein are methods, bacteria, and compositions for the reduction of the amount, activity and/or proliferation of colonic group 3 innate lymphoid cells (ILC3s) and for the treatment and/or prevention of disea...  
WO/2018/233531A1
The present invention provides a microorganism and a use thereof, and a method for obtaining lycopene. The microorganism overexpresses PaCrtE, PagCrtB and BtCrtI genes.  
WO/2018/234603A1
The present invention related to a method for producing and enriching carotenoids from biomass based on the use of nanostructured liquid phases, and use of the carotenoids thus produced as food additives and in the pharmaceutical industry  
WO/2018/234546A1
The application relates to a microorganism, which has been engineered to acquire methylotrophy. More particularly, the application describes a non-naturally occurring microorganism, which has been engineered to express or comprise a firs...  
WO/2018/232574A1
Provided is a microorganism, wherein the microorganism overexpresses TmCrtE, PagCrtB, and BtCrtI genes and silences Exg1 and Ypl062W genes. Also provided are a use of the microorganism and a method of obtaining lycopene using the microor...  
WO/2018/235917A1
The present invention addresses the problem of providing a novel means for assembling vectors in a yeast with high efficiency by inactivating a gene of DNL4 involved in binding heterologous terminals, to completely suppress self-circular...  
WO/2018/234645A1
The present invention relates to a method for preserving a sample of a set of aerobic and anaerobic bacteria other than lactic acid bacteria, in particular intestinal microbiota bacteria, preferably a human stool sample, and a lyophilisa...  
WO/2018/235441A1
Provided is a method and a device for screening continuous culture conditions, capable of selecting a cell line for continuous culture that hardly proliferates after reaching a steady state and that exhibits a high product generation rat...  
WO/2018/230695A1
The problem addressed by the present invention is to provide an agent for the prevention or treatment of fat-related diseases and/or inflammation. The present invention provides an agent for the prevention or treatment of fat-related dis...  
WO/2018/231462A1
The present invention provides engineered transaminase polypeptides useful for the synthesis of chiral amine compounds under industrially relevant conditions. The invention also provides polynucleotides encoding the engineered transamina...  

Matches 1 - 50 out of 103,025